- BLTEBelite Bio$5.9BReported
BLTEQ4 2024
Belite Bio
View full reportEPS
Estimated
-$0.31
Actual
-$0.323.2%
Revenue
Estimated
$0.00
Actual
$0.00
- SAICSAIC$4.5BReported
SAICQ4 2025
SAIC
View full reportEPS
Estimated
$2.02
Actual
$2.000.9%
Revenue
Estimated
$1.8B
Actual
$1.8B0.4%
- ATAIAtai$1.6BReported
ATAIQ4 2024
Atai
View full reportEPS
Estimated
-$0.15
Actual
-$0.2456.1%
Revenue
Estimated
$245.0K
Actual
-$5.00100.0%
- SLDBSolid Biosciences$696MReported
SLDBQ4 2024
Solid Biosciences
View full reportEPS
Estimated
-$0.72
Actual
-$3.06325.0%
Revenue
Estimated
—
Actual
$0.00
- INSEInspired$203MReported
INSEQ4 2024
Inspired
View full reportEPS
Estimated
$0.15
Actual
$2.391508.4%
Revenue
Estimated
$80.1M
Actual
$83.0M3.6%
- PLXProtalix$169MReported
PLXQ4 2024
Protalix
View full reportEPS
Estimated
$0.10
Actual
$0.0459.2%
Revenue
Estimated
$19.8M
Actual
$53.0M167.6%
- NIUNiu$85.0MReported
NIUQ4 2024
Niu
View full reportEPS
Estimated
$0.11
Actual
-$0.11197.6%
Revenue
Estimated
$349.4M
Actual
$112.2M67.9%
- HROWHarrow$1.3BReported
HROWQ4 2024
Harrow
View full reportEPS
Estimated
$0.07
Actual
$0.40469.0%
Revenue
Estimated
$60.3M
Actual
$66.8M10.8%
- HNRGHallador Energy$932MReported
HNRGQ4 2024
Hallador Energy
View full reportEPS
Estimated
-$0.05
Actual
$0.05197.6%
Revenue
Estimated
$104.5M
Actual
$94.2M9.9%
- NRGVEnergy Vault$914MReported
NRGVQ4 2024
Energy Vault
View full reportEPS
Estimated
-$0.11
Actual
-$0.43295.9%
Revenue
Estimated
$41.7M
Actual
$33.5M19.7%
- SANASana$871MReported
SANAQ4 2024
Sana
View full reportEPS
Estimated
-$0.26
Actual
-$0.2311.5%
Revenue
Estimated
—
Actual
$0.00
- FINVFinVolution$674MReported
FINVQ4 2024
FinVolution
View full reportEPS
Estimated
$0.00
Actual
$0.38
Revenue
Estimated
$0.00
Actual
$1.4B
- CTGOContango Ore$614MReported
CTGOQ4 2024
Contango Ore
View full reportEPS
Estimated
-$0.02
Actual
$1.185856.1%
Revenue
Estimated
$5.3M
Actual
$0.00100.0%
- NGSNGS$520MReported
NGSQ4 2024
NGS
View full reportEPS
Estimated
$0.26
Actual
$0.2310.2%
Revenue
Estimated
$40.0M
Actual
$40.7M1.7%
- CWCOConsolidated Water$482MReported
CWCOQ4 2024
Consolidated Water
View full reportEPS
Estimated
$0.29
Actual
$1.12290.2%
Revenue
Estimated
$34.3M
Actual
$134.0M291.0%
- PROKProKidney$257MReported
PROKQ4 2024
ProKidney
View full reportEPS
Estimated
-$0.15
Actual
-$0.166.7%
Revenue
Estimated
—
Actual
$0.00
- TNYATenaya Therapeutics$173MReported
TNYAQ4 2024
Tenaya Therapeutics
View full reportEPS
Estimated
-$0.31
Actual
-$0.289.7%
Revenue
Estimated
$1.0M
Actual
$0.00100.0%
- QTRXQuanterix$144MReported
QTRXQ4 2024
Quanterix
View full reportEPS
Estimated
-$0.22
Actual
-$0.3038.5%
Revenue
Estimated
$34.8M
Actual
$35.2M0.9%
- SGMOSangamo$86.3MReported
SGMOQ4 2024
Sangamo
View full reportEPS
Estimated
-$0.09
Actual
-$0.1122.7%
Revenue
Estimated
$10.1M
Actual
$7.6M25.3%
- QFINQfin Holdings$1.9BReported
QFINQ4 2024
Qfin Holdings
View full reportEPS
Estimated
—
Actual
$1.87
Revenue
Estimated
—
Actual
$614.1M
- INBXInhibrx Biosciences Inc$1.5BReported
INBXQ4 2024
Inhibrx Biosciences Inc
View full reportEPS
Estimated
-$2.88
Actual
-$3.097.3%
Revenue
Estimated
—
Actual
$100.0K
- CCBCoastal Financial$1.1BReported
CCBQ4 2024
Coastal Financial
View full reportEPS
Estimated
$0.96
Actual
$0.941.6%
Revenue
Estimated
$153.8M
Actual
$143.3M6.8%
- BEKEKE Holdings$17.6BReported
BEKEQ4 2024
KE Holdings
View full reportEPS
Estimated
$0.28
Actual
$0.1642.2%
Revenue
Estimated
$3.7B
Actual
$4.3B16.1%
- NVMINova$16.1BReported
NVMIQ4 2024
Nova
View full reportEPS
Estimated
$1.84
Actual
$1.945.4%
Revenue
Estimated
$189.6M
Actual
$194.8M2.7%
- TMETencent Music$5.4BReported
TMEQ4 2024
Tencent Music
View full reportEPS
Estimated
$0.18
Actual
$0.175.8%
Revenue
Estimated
$1.1B
Actual
$1.0B3.5%
- IHSIHS$2.8BReported
IHSQ4 2024
IHS
View full reportEPS
Estimated
$0.08
Actual
$0.74802.4%
Revenue
Estimated
$422.0M
Actual
$1.7B305.4%
- STOKStoke Therapeutics$2.0BReported
STOKQ4 2024
Stoke Therapeutics
View full reportEPS
Estimated
-$0.55
Actual
-$0.1867.5%
Revenue
Estimated
$4.2M
Actual
$22.6M438.1%
- EVEXEve$1.2BReported
EVEXQ4 2024
Eve
View full reportEPS
Estimated
-$0.18
Actual
-$0.1424.1%
Revenue
Estimated
—
Actual
$0.00
- ETONEton$873MReported
ETONQ4 2024
Eton
View full reportEPS
Estimated
$0.00
Actual
-$0.02
Revenue
Estimated
$10.4M
Actual
$11.6M11.9%
- TIGRUP Fintech$858MReported
TIGRQ4 2024
UP Fintech
View full reportEPS
Estimated
$0.11
Actual
$0.1752.5%
Revenue
Estimated
$73.8M
Actual
$391.5M430.8%
- ITOSiTeos Therapeutics$449MReported
ITOSQ4 2024
iTeos Therapeutics
View full reportEPS
Estimated
-$1.02
Actual
-$1.011.0%
Revenue
Estimated
—
Actual
$0.00
- CTRNCiti Trends$422MReported
CTRNQ4 2024
Citi Trends
View full reportEPS
Estimated
$0.18
Actual
-$1.54934.7%
Revenue
Estimated
$202.1M
Actual
$211.2M4.5%
- SNDLSNDL$386MReported
SNDLQ4 2024
SNDL
View full reportEPS
Estimated
-$0.01
Actual
-$0.181725.0%
Revenue
Estimated
$248.1M
Actual
$257.7M3.9%
- HUYAHUYA$204MReported
HUYAQ4 2024
HUYA
View full reportEPS
Estimated
$0.28
Actual
$0.00100.0%
Revenue
Estimated
$1.6B
Actual
$204.9M86.9%
- CRBPCorbus Pharmaceuticals$142MReported
CRBPQ4 2024
Corbus Pharmaceuticals
View full reportEPS
Estimated
-$1.22
Actual
-$0.7836.1%
Revenue
Estimated
—
Actual
$0.00
- HQYHealthEquity$7.6BReported
HQYQ4 2025
HealthEquity
View full reportEPS
Estimated
$0.74
Actual
$0.696.5%
Revenue
Estimated
$795.2M
Actual
$311.8M60.8%
- FIZZNational Beverage$3.5BReported
FIZZQ3 2025
National Beverage
View full reportEPS
Estimated
$0.45
Actual
$0.426.7%
Revenue
Estimated
$282.2M
Actual
$267.1M5.4%
- STNEStoneCo$2.8BReported
STNEQ4 2024
StoneCo
View full reportEPS
Estimated
$0.36
Actual
-$0.81325.8%
Revenue
Estimated
$660.5M
Actual
$2.1B224.1%
- NUVBNuvation Bio$1.7BReported
NUVBQ4 2024
Nuvation Bio
View full reportEPS
Estimated
-$0.14
Actual
-$0.157.1%
Revenue
Estimated
—
Actual
$5.7M
- OLMAOlema$1.1BReported
OLMAQ4 2024
Olema
View full reportEPS
Estimated
$0.17
Actual
-$0.51400.0%
Revenue
Estimated
—
Actual
$0.00
- ABSIAbsci$948MReported
ABSIQ4 2024
Absci
View full reportEPS
Estimated
-$0.21
Actual
-$0.2516.8%
Revenue
Estimated
$1.8M
Actual
$665.0K62.7%
- MRVIMaravai$684MReported
MRVIQ4 2024
Maravai
View full reportEPS
Estimated
-$0.04
Actual
$0.00100.0%
Revenue
Estimated
$60.0M
Actual
$56.6M5.7%
- DSGNDesign Therapeutics$671MReported
DSGNQ4 2024
Design Therapeutics
View full reportEPS
Estimated
-$0.27
Actual
-$0.2411.1%
Revenue
Estimated
—
Actual
$0.00
- OLPOne Liberty Properties$517MReported
OLPQ4 2024
One Liberty Properties
View full reportEPS
Estimated
$0.50
Actual
$0.492.0%
Revenue
Estimated
$23.0M
Actual
$23.9M4.0%
- OABIOmniAb$394MReported
OABIQ4 2024
OmniAb
View full reportEPS
Estimated
-$0.10
Actual
-$0.1222.1%
Revenue
Estimated
$9.9M
Actual
$10.8M8.8%
- LYELLyell Immunopharma$393MReported
LYELQ4 2024
Lyell Immunopharma
View full reportEPS
Estimated
-$0.13
Actual
-$45867.0035282207.7%
Revenue
Estimated
—
Actual
$11.00
- PRLDPrelude Therapeutics$313MReported
PRLDQ4 2024
Prelude Therapeutics
View full reportEPS
Estimated
-$0.47
Actual
-$1.68257.4%
Revenue
Estimated
—
Actual
$7.0K
- FATEFate Therapeutics$307MReported
FATEQ4 2024
Fate Therapeutics
View full reportEPS
Estimated
-$0.43
Actual
-$0.442.3%
Revenue
Estimated
$1.6M
Actual
$1.9M21.0%
- OKURReneo Pharmaceuticals$56.3MReported
OKURQ4 2024
Reneo Pharmaceuticals
View full reportEPS
Estimated
-$0.74
Actual
-$1.3785.1%
Revenue
Estimated
—
Actual
$0.00
- WSMWilliams-Sonoma$24.2BReported
WSMQ4 2024
Williams-Sonoma
View full reportEPS
Estimated
$2.82
Actual
$3.2816.4%
Revenue
Estimated
$2.3B
Actual
$2.5B7.4%
- GISGeneral Mills$18.1BReported
GISQ3 2025
General Mills
View full reportEPS
Estimated
$0.99
Actual
$1.1213.1%
Revenue
Estimated
$5.2B
Actual
$4.8B6.4%
- GDSGDS$7.1BReported
GDSQ4 2024
GDS
View full reportEPS
Estimated
-$0.33
Actual
-$0.1360.8%
Revenue
Estimated
$433.0M
Actual
$10.3B2284.1%
- LQDALiquidia$5.5BReported
LQDAQ4 2024
Liquidia
View full reportEPS
Estimated
-$0.41
Actual
-$0.434.9%
Revenue
Estimated
$4.4M
Actual
$14.0M218.6%
- OLLIOllie's$5.0BReported
OLLIQ4 2024
Ollie's
View full reportEPS
Estimated
$1.17
Actual
$1.115.4%
Revenue
Estimated
$602.1M
Actual
$667.1M10.8%
- CAAPCAAP$4.3BReported
CAAPQ4 2024
CAAP
View full reportEPS
Estimated
$0.15
Actual
$0.2138.0%
Revenue
Estimated
$380.5M
Actual
$461.1M21.2%
- SIGSignet$3.4BReported
SIGQ4 2025
Signet
View full reportEPS
Estimated
$7.57
Actual
$2.3069.6%
Revenue
Estimated
$1.9B
Actual
$2.4B25.4%
- VERAVera$2.6BReported
VERAQ4 2024
Vera
View full reportEPS
Estimated
-$0.83
Actual
-$2.75231.3%
Revenue
Estimated
—
Actual
$0.00
- JILLJJill$198MReported
JILLQ4 2024
JJill
View full reportEPS
Estimated
$0.21
Actual
$0.3252.2%
Revenue
Estimated
$139.5M
Actual
$610.9M337.8%
- FIVEFive Below$12.4BReported
FIVEQ4 2024
Five Below
View full reportEPS
Estimated
$3.54
Actual
$3.394.3%
Revenue
Estimated
$1.3B
Actual
$1.4B3.1%
- TREXTrex$4.4BReported
TREXQ4 2024
Trex
View full reportEPS
Estimated
$0.04
Actual
$0.09130.8%
Revenue
Estimated
$156.7M
Actual
$168.0M7.2%
- IMNMImmunome$2.6BReported
IMNMQ4 2024
Immunome
View full reportEPS
Estimated
-$0.72
Actual
-$5.00594.4%
Revenue
Estimated
$3.1M
Actual
$9.0K99.7%
- JOYYJOYY$2.2BReported
JOYYQ4 2024
JOYY
View full reportEPS
Estimated
$1.01
Actual
$1.7776.0%
Revenue
Estimated
$565.2M
Actual
$2.2B289.2%
- LARLithium Americas Argentina C$1.7BReported
LARQ4 2024
Lithium Americas Argentina C
View full reportEPS
Estimated
$0.03
Actual
-$0.03198.7%
Revenue
Estimated
—
Actual
$197.7M
- CAPRCapricor$1.7BReported
CAPRQ4 2024
Capricor
View full reportEPS
Estimated
-$0.09
Actual
-$0.1682.3%
Revenue
Estimated
$9.7M
Actual
$11.1M15.1%
- PGENPrecigen$1.6BReported
PGENQ4 2024
Precigen
View full reportEPS
Estimated
-$0.06
Actual
-$0.47702.7%
Revenue
Estimated
$1.3M
Actual
$1.2M6.6%
- BKKTBakkt$491MReported
BKKTQ4 2024
Bakkt
View full reportEPS
Estimated
-$1.22
Actual
-$2.95142.1%
Revenue
Estimated
$21.2M
Actual
$1.8B8386.7%
- SCPHscPharmaceuticals$293MReported
SCPHQ4 2024
scPharmaceuticals
View full reportEPS
Estimated
-$0.39
Actual
-$0.359.5%
Revenue
Estimated
$11.9M
Actual
$12.2M2.2%
- SERASera Prognostics$83.8MReported
SERAQ4 2024
Sera Prognostics
View full reportEPS
Estimated
-$0.24
Actual
-$0.256.4%
Revenue
Estimated
$15.3K
Actual
$24.0K56.9%
- ORLAOrla Mining Ltd$4.3BReported
ORLAQ4 2025
Orla Mining Ltd
View full reportEPS
Estimated
—
Actual
—
Revenue
Estimated
—
Actual
$140.7M
- PDDPDD Holdings$118BReported
PDDQ4 2024
PDD Holdings
View full reportEPS
Estimated
$2.62
Actual
$2.765.2%
Revenue
Estimated
$16.0B
Actual
$54.0B237.4%
- ACNAccenture$110BReported
ACNQ2 2025
Accenture
View full reportEPS
Estimated
$2.80
Actual
$2.820.8%
Revenue
Estimated
$16.6B
Actual
$16.7B0.5%
- JBLJabil$38.4BReported
JBLQ2 2025
Jabil
View full reportEPS
Estimated
$1.88
Actual
$1.0643.7%
Revenue
Estimated
$6.4B
Actual
$6.7B4.7%
- DRIDarden$23.4BReported
DRIQ3 2025
Darden
View full reportEPS
Estimated
$2.76
Actual
$2.740.6%
Revenue
Estimated
$3.2B
Actual
$3.2B0.7%
- HTHTHuazhu$13.7BReported
HTHTQ4 2024
Huazhu
View full reportEPS
Estimated
$0.35
Actual
$0.1460.4%
Revenue
Estimated
$896.6M
Actual
$23.9B2564.7%
- SUNSunoco$9.1BReported
SUNQ4 2024
Sunoco
View full reportEPS
Estimated
$1.32
Actual
$0.7543.4%
Revenue
Estimated
$6.0B
Actual
$5.3B12.7%
- FDSFactSet$8.7BReported
FDSQ2 2025
FactSet
View full reportEPS
Estimated
$4.22
Actual
$3.7610.9%
Revenue
Estimated
$577.6M
Actual
$570.7M1.2%
- CMCCommercial Metals$8.5BReported
CMCQ2 2025
Commercial Metals
View full reportEPS
Estimated
$0.78
Actual
$0.2271.6%
Revenue
Estimated
$1.8B
Actual
$1.8B4.3%
- ASOAcademy Sports$3.6BReported
ASOQ4 2024
Academy Sports
View full reportEPS
Estimated
$1.84
Actual
$1.892.7%
Revenue
Estimated
$1.7B
Actual
$1.7B0.2%
- GLUEMonte Rosa Therapeutics$1.6BReported
GLUEQ4 2024
Monte Rosa Therapeutics
View full reportEPS
Estimated
$0.11
Actual
$0.22100.6%
Revenue
Estimated
$52.2M
Actual
$60.6M16.1%
- SPRYARS Pharmaceuticals$933MReported
SPRYQ4 2024
ARS Pharmaceuticals
View full reportEPS
Estimated
-$0.11
Actual
$0.48547.6%
Revenue
Estimated
$17.4M
Actual
$86.6M397.1%
- GROYGold Royalty$739MReported
GROYQ1 2025
Gold Royalty
View full reportEPS
Estimated
$0.00
Actual
-$0.02
Revenue
Estimated
$5.0M
Actual
$3.4M33.4%
- TITNTitan Machinery$507MReported
TITNQ4 2025
Titan Machinery
View full reportEPS
Estimated
-$0.62
Actual
-$1.93211.5%
Revenue
Estimated
$713.6M
Actual
$759.9M6.5%
- CALCaleres$495MReported
CALQ4 2024
Caleres
View full reportEPS
Estimated
$0.96
Actual
$0.1584.4%
Revenue
Estimated
$679.7M
Actual
$639.2M6.0%
- MUMicron$1.04TReported
MUQ2 2025
Micron
View full reportEPS
Estimated
$1.47
Actual
$1.414.3%
Revenue
Estimated
$8.0B
Actual
$8.1B0.3%
- FDXFedEx$98.2BReported
FDXQ3 2025
FedEx
View full reportEPS
Estimated
$4.72
Actual
$3.7620.3%
Revenue
Estimated
$22.2B
Actual
$22.2B0.0%
- NKENike$70.1BReported
NKEQ3 2025
Nike
View full reportEPS
Estimated
$0.28
Actual
$0.5495.2%
Revenue
Estimated
$11.1B
Actual
$11.3B1.7%
- IRENIREN Ltd$22.9BReported
IRENQ2 2025
IREN Ltd
View full reportEPS
Estimated
-$0.04
Actual
—
Revenue
Estimated
$168.0M
Actual
$119.6M28.8%
- LENLennar$22.1BReported
LENQ1 2025
Lennar
View full reportEPS
Estimated
$1.74
Actual
$1.9612.4%
Revenue
Estimated
$7.4B
Actual
$7.6B3.2%
- PLPlanet Labs$17.8BReported
PLQ4 2024
Planet Labs
View full reportEPS
Estimated
-$0.02
Actual
-$0.12487.1%
Revenue
Estimated
$59.7M
Actual
$61.6M3.2%
- TERNTerns$6.1BReported
TERNQ4 2024
Terns
View full reportEPS
Estimated
-$0.30
Actual
-$0.2420.0%
Revenue
Estimated
—
Actual
$0.00
- AMPXAmprius$3.0BReported
AMPXQ4 2024
Amprius
View full reportEPS
Estimated
-$0.10
Actual
-$0.102.4%
Revenue
Estimated
$7.0M
Actual
$10.6M51.9%
- OUSTOuster$2.7BReported
OUSTQ4 2024
Ouster
View full reportEPS
Estimated
-$0.27
Actual
-$0.4880.1%
Revenue
Estimated
$30.0M
Actual
$30.0M0.0%
- SCHLScholastic$889MReported
SCHLQ3 2025
Scholastic
View full reportEPS
Estimated
-$0.78
Actual
-$0.1383.3%
Revenue
Estimated
$351.3M
Actual
$335.4M4.5%
- KLCKindercare Learning Cos Inc$452MReported
KLCQ2 2024
Kindercare Learning Cos Inc
View full reportEPS
Estimated
$0.05
Actual
$0.0978.7%
Revenue
Estimated
$632.5M
Actual
$647.0M2.3%
- VSTMVerastem$377MReported
VSTMQ4 2024
Verastem
View full reportEPS
Estimated
-$0.72
Actual
-$0.6016.8%
Revenue
Estimated
$153.0K
Actual
$0.00100.0%
- RWAYRunway Growth$277MReported
RWAYQ4 2024
Runway Growth
View full reportEPS
Estimated
$0.40
Actual
$0.392.7%
Revenue
Estimated
$36.2M
Actual
$33.8M6.7%
- MGNXMacroGenics$268MReported
MGNXQ4 2024
MacroGenics
View full reportEPS
Estimated
-$0.66
Actual
-$1.0762.1%
Revenue
Estimated
$30.9M
Actual
$150.0M384.8%
- CCLCarnival$34.6BReported
CCLQ1 2025
Carnival
View full reportEPS
Estimated
-$0.01
Actual
-$0.061070.7%
Revenue
Estimated
$5.9B
Actual
$5.8B1.5%
- CUKCarnival$26.4BReported
CUKQ1 2025
Carnival
View full reportEPS
Estimated
$0.00
Actual
-$0.06
Revenue
Estimated
$0.00
Actual
$5.8B
- MNSOMINISO$3.8BReported
MNSOQ4 2024
MINISO
View full reportEPS
Estimated
$0.28
Actual
$0.3525.0%
Revenue
Estimated
$566.0M
Actual
$645.6M14.1%
- MBRXMoleculin$14.6MReported
MBRXQ4 2024
Moleculin
View full reportEPS
Estimated
-$1.33
Actual
-$6.32375.2%
Revenue
Estimated
—
Actual
$0.00